Healthcare of Ontario Pension Plan (HOOPP) Trust Fund’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-125,300
Closed -$4.51M 1209
2023
Q1
$4.51M Buy
+125,300
New +$5.41M 0.02% 373
2022
Q4
Sell
-45,000
Closed -$1.26M 1437
2022
Q3
$1.26M Buy
+45,000
New +$1.38M 0.01% 839

Other funds holding CLDX

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's CLDX Position: Q2 2023 in Review

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund sold out of Celldex Therapeutics (CLDX) in Q2 2023, closing a stake of 125,300 shares — an estimated $4.51M sold.

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in CLDX in Q3 2022 and held it in 2 quarters. The position peaked at $4.51M in Q1 2023. 150 funds tracked by Wall St. Rank hold CLDX as of Q2 2023.

  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund reported no remaining Celldex Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund sold 125,300 Celldex Therapeutics shares in Q2 2023, an estimated $4.51M.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund first reported a position in Celldex Therapeutics in Q3 2022 and held it in 2 quarters.
  • Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's Celldex Therapeutics position peaked at $4.51M in Q1 2023.
  • 150 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q2 2023.

Based on Healthcare of Ontario Pension Plan (HOOPP) Trust Fund's 13F filing for Q2 2023, filed 11 Aug 2023.